Both candidates are designed to move beyond single-pathway GLP-1 therapy, but they take very different routes: CagriSema combines an amylin analog with semaglutide, while Retatrutide compresses GIP, GLP-1, and glucagon agonism into one investigational peptide
In another study, an 84-week open-label trial with about 800 participants, people taking CagriSema had an average of 23% weight loss versus about 25 to 26% for tirzepatide (Zepbound) at the highest dose
The micro-channels created by needling dramatically improve peptide absorption
This guide explains what MOTS-C is, how scientists believe it works, what research has found, what remains unknown, and what U.S
The benefits of peptides are realbut only when used responsibly
Quercetin is often used to support the respiratory system, while glutathione is essential for the proper function of T-cells and white blood cells